Pfizer And Moderna’s Cold War On COVID Gets Competitive

Biotech Talks Up Refrigeration Advantage

 
• By Andrew McConaghie

Ahead of anticipated emergency use approvals, Pfizer and Moderna are promoting the benefits of their rival mRNA vaccines.

Dry Ice
Dry ice pellets, like those that will be used to keep Pfizer/BioNTech's vaccine at -70°C

More from Business

More from Scrip